Biopharma Innovation — Value At Any Price?
Biopharma Innovation — Value At Any Price?
In March I attended The Conference Forum’s R&D Leadership Summit. One of the panels that provided a great deal of insight involved executives discussing how to assess and create value for patients, payors, regulators, and society. This event employs the Chatham House Rule, which means “Neither the identity nor the affiliation of the speaker(s), nor that of any other participant, may be revealed.” Despite not being able to...  Continue Reading..
BIO 2017
Are You Ready For BIO 2017 In San Diego?
With the BIO International 2017 Convention being just seven weeks away, your preparations as an attendee should be well underway. But until they arrive on-site, many people often overlook deciding what educational sessions to attend. And while BIO attendees can afford to take such an approach, speakers certainly cannot. As the past BIO educational planning co-chair, I can attest that a lot of work goes into pulling off a high-quality educational...  Continue Reading..
Who Is The Biopharmaceutical Industry CEO Of The Year?
Who Is The Biopharmaceutical Industry CEO Of The Year?
I’ve been thinking, if you were going to name someone to be the biopharmaceutical industry CEO of the year, who would it be? But even more important than the who is the why. What criteria would you use? I’ve been looking through a bunch of articles that list top influencers for our industry, and the criterion for inclusion seems pretty subjective. There are media outlets that employ a variety of objective measures (i.e., company...  Continue Reading..
With Repeal And Replace Dead, Biopharma Still Has Plenty On Which To Focus
With Repeal And Replace Dead, Biopharma Still Has Plenty On Which To Focus
Not long ago I had the opportunity to go to an invitation-only event attended by some of the biopharmaceutical industry’s biggest thought leaders. At the time, Repeal and Replace of the Affordable Care Act (ACA) was a priority for the new administration. But now that it has failed, you might be wondering what else should folks in biopharma be paying attention to?  Continue Reading..
John Crowley
John Crowley — A Biopharma Bright Spot
While watching President Trump address Congress on February, 28, 2017, I saw someone I knew -- John Crowley, the founder and CEO of Amicus Therapeutics.  Continue Reading..
Readying For The R&D Leadership Summit 2017
Readying For The R&D Leadership Summit 2017
I will be attending one of my all-time favorite conferences this week (March 9 – 10), the R&D Leadership Summit put on by The Conference Forums’ Valerie Bowling. While some might find the organization’s employment of the Chatham House Rule to be too restrictive for someone like me to be able to come away with useful insights that could be shared, my experience has been quite to the contrary.  Continue Reading..
Inovio Pharmaceuticals Is Doing More Than Just Creating Buzz At BIO CEO 2017
Inovio Pharmaceuticals Is Doing More Than Just Creating Buzz At BIO CEO 2017
When invited to host the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City on behalf of Life Science Leader magazine, I did not know who I’d be interviewing, just that I’d be doing about five video interviews with a number of industry executives and thought leaders.  Continue Reading..
What Is BIO’s Focus For 2017 And Beyond? More Buzz From BIO CEO
What Is BIO’s Focus For 2017 And Beyond? More Buzz From BIO CEO
Hosting the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City on behalf of Life Science Leader magazine provided me the opportunity to conduct five video interviews with a number of industry executives and thought leaders.  Continue Reading..
From Hospital Research Project To Spark Therapeutics – Just One Of The Companies Creating Buzz At BIO CEO 2017
From Hospital Research Project To Spark Therapeutics – Just One Of The Companies Creating Buzz At BIO CEO 2017
As host of the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City, Life Science Leader magazine conducted five video interviews with a number of industry executives and thought leaders.  Continue Reading..
Myovant Sciences CEO Creates Buzz At 2017 BIO CEO & Investor Conference
Myovant Sciences CEO Creates Buzz At 2017 BIO CEO & Investor Conference
As host of the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City, Life Science Leader magazine had the opportunity to conduct five video interviews with a number of industry executives and thought leaders.  Continue Reading..
Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL